HSAI

The Week

Hesai (HSAI.US) fell 4.56% this week to $16.52, against a 0.08% decline in the S&P 500, underperforming the benchmark by about 4.48 percentage points. The stock opened Monday near the week’s high of $17.39, then drifted lower through the week, hitting an intraday low of $16.395 on Friday. Weekly amplitude was 5.85%, and average daily volume ran roughly 22% below the prior median.

Key Events

Hesai’s week centred on patent litigation and a new partnership. On 15 September, the company announced a strategic tie-up with JD to expand business around unmanned logistics vehicles using 6D full-colour LiDAR. On 17 September, Hesai filed its Form 6-K and published its 2026 interim report. On 18 September, Seyond Holdings said two LiDAR patent lawsuits were voluntarily withdrawn after the patents were invalidated, and the court permitted the withdrawal, with Hesai also pulling the related cases. The move trimmed some legal uncertainty around the name.

Analyst Ratings

A total of 20 brokers cover Hesai, with 15 rating it buy and 5 rating it overweight; there are no hold, underweight or sell ratings. The consensus rating is strong buy, with a consensus target of $28.34, about 71.5% above the latest close of $16.52. Individual targets range from $21.643 to $36.185, pointing to a wide spread of views. Within the auto parts and equipment industry, Hesai ranks 2nd out of 37 names on analyst coverage and has more brokers covering it than the industry average.

The Week Ahead

The coming week brings a run of US macro releases. The Richmond Fed composite index arrives on 22 September, followed by EIA crude oil data on 23 September and jobless claims plus the current account balance on 24 September. For a name closely tied to the auto supply chain, macro sentiment and liquidity remain the main external drivers. Whether the withdrawn patent suits produce any follow-up legal action will also be worth watching.

In Short

The week left Hesai with a tension between fundamentals and price action. Brokers hold a strong-buy consensus and a target well above spot, yet the stock fell and lagged the market, while the latest session’s capital flow showed large and medium orders on the sell side. The patent withdrawal and JD partnership offer positive signals, but near-term valuation and money flow have not aligned. The focus now shifts to macro data and whether the stock can hold above $16.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.